JP7463491B2 - 被験者のグルコース変化を判定するための方法およびシステム - Google Patents

被験者のグルコース変化を判定するための方法およびシステム Download PDF

Info

Publication number
JP7463491B2
JP7463491B2 JP2022500661A JP2022500661A JP7463491B2 JP 7463491 B2 JP7463491 B2 JP 7463491B2 JP 2022500661 A JP2022500661 A JP 2022500661A JP 2022500661 A JP2022500661 A JP 2022500661A JP 7463491 B2 JP7463491 B2 JP 7463491B2
Authority
JP
Japan
Prior art keywords
meal
subject
glucose
model parameters
innovation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022500661A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539818A (ja
Inventor
エル・ファティ，アナス
ハイダル，アーマド
Original Assignee
イーライ リリー アンド カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イーライ リリー アンド カンパニー filed Critical イーライ リリー アンド カンパニー
Publication of JP2022539818A publication Critical patent/JP2022539818A/ja
Priority to JP2024051853A priority Critical patent/JP7785832B2/ja
Application granted granted Critical
Publication of JP7463491B2 publication Critical patent/JP7463491B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/725—Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2022500661A 2019-07-09 2020-07-09 被験者のグルコース変化を判定するための方法およびシステム Active JP7463491B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024051853A JP7785832B2 (ja) 2019-07-09 2024-03-27 被験者のグルコース変化を判定するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962871931P 2019-07-09 2019-07-09
US62/871,931 2019-07-09
PCT/IB2020/056467 WO2021005552A1 (en) 2019-07-09 2020-07-09 Method and system for determining glucose change in a subject

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024051853A Division JP7785832B2 (ja) 2019-07-09 2024-03-27 被験者のグルコース変化を判定するための方法

Publications (2)

Publication Number Publication Date
JP2022539818A JP2022539818A (ja) 2022-09-13
JP7463491B2 true JP7463491B2 (ja) 2024-04-08

Family

ID=74114442

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022500661A Active JP7463491B2 (ja) 2019-07-09 2020-07-09 被験者のグルコース変化を判定するための方法およびシステム
JP2024051853A Active JP7785832B2 (ja) 2019-07-09 2024-03-27 被験者のグルコース変化を判定するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024051853A Active JP7785832B2 (ja) 2019-07-09 2024-03-27 被験者のグルコース変化を判定するための方法

Country Status (7)

Country Link
US (1) US20220280720A1 (enExample)
EP (1) EP3997712A4 (enExample)
JP (2) JP7463491B2 (enExample)
CN (1) CN114127860A (enExample)
AU (2) AU2020310616A1 (enExample)
CA (1) CA3146060A1 (enExample)
WO (1) WO2021005552A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220088303A1 (en) * 2020-09-21 2022-03-24 Insulet Corporation Techniques for determining automated insulin delivery dosages
WO2022169856A1 (en) * 2021-02-03 2022-08-11 Abbott Diabetes Care Inc. Systems, devices, and methods relating to medication dose guidance
FR3139456A1 (fr) * 2022-09-13 2024-03-15 Diabeloop Système permettant de compenser un repas imprévu ingéré
FR3139659A1 (fr) * 2022-09-13 2024-03-15 Diabeloop Système permettant d'estimer un repas imprévu ingéré

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160354543A1 (en) 2015-06-02 2016-12-08 Ali Cinar Multivariable artificial pancreas method and system
JP2017501765A (ja) 2013-11-14 2017-01-19 リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア グルコース率増加検出器：ヘルスモニタリングシステム用の食事検出モジュール
WO2019125932A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572545B2 (en) * 2000-09-22 2003-06-03 Knobbe, Lim & Buckingham Method and apparatus for real-time control of physiological parameters
US10478556B2 (en) * 2016-03-04 2019-11-19 Roche Diabetes Care, Inc. Probability based controller gain
US10792423B2 (en) * 2016-04-13 2020-10-06 The Trustees Of The University Of Pennsylvania Methods, systems, and computer readable media for physiology parameter-invariant meal detection
CN116531603A (zh) * 2017-05-05 2023-08-04 伊莱利利公司 生理葡萄糖的闭环控制

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017501765A (ja) 2013-11-14 2017-01-19 リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア グルコース率増加検出器：ヘルスモニタリングシステム用の食事検出モジュール
US20160354543A1 (en) 2015-06-02 2016-12-08 Ali Cinar Multivariable artificial pancreas method and system
WO2019125932A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAMERON et al，Probabilistic Evolving Meal Detection and Estimation of Meal Total Glucose Appearance，Journal of Diabetes Science and Technology，Diabetes Technology Society，2009年09月30日，Vol.3, Issue 5，p.1022-1030，[検索日 2023年2月22日], インターネット：＜URL: https://journals.sagepub.com/doi/pdf/10.1177/193229680900300505＞

Also Published As

Publication number Publication date
CA3146060A1 (en) 2021-01-14
WO2021005552A1 (en) 2021-01-14
JP2022539818A (ja) 2022-09-13
AU2020310616A1 (en) 2022-01-20
US20220280720A1 (en) 2022-09-08
JP2024099522A (ja) 2024-07-25
CN114127860A (zh) 2022-03-01
AU2023278117A1 (en) 2024-01-04
EP3997712A4 (en) 2023-07-12
JP7785832B2 (ja) 2025-12-15
EP3997712A1 (en) 2022-05-18

Similar Documents

Publication Publication Date Title
JP7785832B2 (ja) 被験者のグルコース変化を判定するための方法
Turksoy et al. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement
Georga et al. A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditions
CN102596307B (zh) 利用名义开环特性在糖尿病中进行胰岛素输送调节(aid)的系统、方法和计算机程序产品
EP2475356B1 (en) Devices, systems and methods for adjusting fluid delivery parameters
EP3902469B1 (en) Evaluation and visualization of glycemic dysfunction
US10456090B2 (en) Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
WO2015056259A1 (en) System and method for improved artificial pancreas management
Miller et al. Automatic learning algorithm for the MD-logic artificial pancreas system
JP6957509B2 (ja) 過去の予測を使用する人工膵臓のための予測制御モデル
US20230005587A1 (en) Determining whether adjustments of insulin therapy recommendations are being taken into account
El Fathi et al. An unannounced meal detection module for artificial pancreas control systems
Takahashi et al. A Survey of Insulin‐Dependent Diabetes—Part II: Control Methods
US20230005586A1 (en) Determining total daily basal dose mismatch
Cescon et al. Subspace-based linear multi-step predictors in type 1 diabetes mellitus
Hughes et al. Anticipating the next meal using meal behavioral profiles: A hybrid model-based stochastic predictive control algorithm for T1DM
CN116762136A (zh) 基于风险的胰岛素输送转换的系统和方法
Benam et al. Estimation and prediction of glucose appearance rate for use in a fully closed-loop dual-hormone intraperitoneal artificial pancreas
Beck et al. Challenges for outpatient closed loop studies: how to assess efficacy
Fravolini et al. An iterative learning strategy for the auto-tuning of the feedforward and feedback controller in type-1 diabetes
US11931548B2 (en) Method and system for determining optimal and recommended therapy parameters for diabetic subject
JP2024534430A (ja) 高血糖を減少させるためのオンライン外乱除去及び予測システム
Dias et al. Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm
Boiroux Model predictive control algorithms for pen and pump insulin administration
US20230338654A1 (en) System and method for titrating basal insulin doses

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220106

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230307

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230606

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230804

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240213

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240327

R150 Certificate of patent or registration of utility model

Ref document number: 7463491

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150